$HUN

Huntsman Corporation (HUN) Reports $18M Net Loss; Adjusted EBITDA $132M

Huntsman Corporation reported Q3 2026 revenue of $1.717B, a net loss of $18M, adjusted net income of $7M, and adjusted EBITDA of $132M. Free cash flow decreased to $82M from $157M a year earlier. The company is in a planned merger process, with segment results improving year over year but lower cash flow.

Original reporting
Published Nov 2, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Huntsman Corporation (HUN) Reports $18M Net Loss; Adjusted EBITDA $132M — source image
Decision brief

The 30-second read

$HUNBearishMed
01

Why it matters

The loss and cash flow decline could weigh on the stock, but merger‑related catalysts may offset downside.

02

Market read

Earnings miss with negative cash flow signals short‑term downside, but merger outlook adds uncertainty.

03

What to watch

Potential upside from upcoming merger approvals and future quarterly improvements.

Relevance 7/10Novelty 8/10Timing: post‑market release

Background

Huntsman is in a planned merger process; the earnings release provides an update on operating performance.

Company-level read

Ticker impact

$HUNBearishHigh confidence
Context

Huntsman reported Q3 2026 revenue of $1.717B, a net loss of $18M and adjusted EBITDA of $132M.

Expected impact

likely pressure as investors price in the net loss and weaker cash generation

Evidence & confidence

The loss and lower free cash flow contrast with prior year, prompting a sell‑off.

Market effects

Chemicals sector may see modest pullback as a mid‑cap peer reports weaker cash flow.

U.S. market may see slight dip in related industrial stocks.

Limited; impact confined to Huntsman and its immediate peers.

Counterpoint

If the merger proceeds, the loss may be viewed as a short‑term cost, offering a buying opportunity.

Key entities

  • Huntsman Corporation

    U.S. chemicals manufacturer undergoing a merger.

Related articles

$HUNMed

Huntsman Q3 Earnings Call Highlights

Huntsman (HUN) reported Q3 earnings, noting seasonal slowing and higher raw-material costs in North American MDI markets. The company expects 2027 industry MDI growth to be flat to 2% and sees growth opportunities in advanced materials and automotive applications. Huntsman generated $82M in free cash flow in Q3 and anticipates substantial cash inflow in Q4. Europe remains challenging due to high energy costs, while China's market shows stability.

$HUNMed

Huntsman Corp (HUN) (Q3 2026) Earnings Call Highlights: $100 Million EBITDA Boost

Huntsman Corp (HUN) reported a $100M EBITDA boost in Q3 2026, with CEO Peter Huntsman expressing confidence in meeting $300M synergy targets from the Olin merger. He discussed market positioning, cost management, and growth expectations, including GDP-plus growth in Advanced Materials through 2027. The company expects to cover its dividend and capex with operating cash flow, despite minimal cash flow in the first nine months.

$HUNMedAI 8/10

Huntsman: Q3 Earnings Snapshot

Huntsman Corp. (HUN) reported a Q3 loss of $18M, or 10 cents per share, missing analyst expectations of 7 cents per share. Adjusted earnings were 4 cents per share. Revenue was $1.72B, exceeding forecasts of $1.6B.